{"id":"ah5n1c","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This vaccine works by introducing a piece of the H5N1 virus to the body, which triggers an immune response and helps the body develop antibodies to fight the virus. The vaccine is designed to provide protection against severe illness and death caused by the H5N1 virus.","oneSentence":"aH5N1c is a vaccine that stimulates the body's immune response to the H5N1 subtype of the influenza A virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:59:52.300Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of influenza caused by the H5N1 subtype of the influenza A virus"}]},"trialDetails":[{"nctId":"NCT02839330","phase":"PHASE3","title":"A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age","status":"COMPLETED","sponsor":"Seqirus","startDate":"2016-07-11","conditions":"Avian Influenza","enrollment":3196},{"nctId":"NCT05422326","phase":"PHASE2","title":"A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed","status":"COMPLETED","sponsor":"Seqirus","startDate":"2022-07-18","conditions":"Influenza, Human, Influenza in Birds, Respiratory Tract Infections","enrollment":260},{"nctId":"NCT01766921","phase":"PHASE2","title":"Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2013-01","conditions":"Pandemic H5N1 Influenza","enrollment":1393},{"nctId":"NCT01776554","phase":"PHASE2","title":"Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2013-01","conditions":"Pandemic H5N1 Influenza","enrollment":662},{"nctId":"NCT01776541","phase":"PHASE2","title":"Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2013-01","conditions":"Pandemic H5N1 Influenza","enrollment":979}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"aH5N1c","genericName":"aH5N1c","companyName":"Seqirus","companyId":"seqirus","modality":"Biologic","firstApprovalDate":"","aiSummary":"aH5N1c is a vaccine that stimulates the body's immune response to the H5N1 subtype of the influenza A virus. Used for Prevention of influenza caused by the H5N1 subtype of the influenza A virus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}